 ImmuCell Corporation Nasdaq: ICCC ImmuCell or the Company, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle, today announced a complete refinancing of its bank debt. The Company closed on an 8.6 million debt refinancing package with Gorham Savings Bank comprised of three components. The first is a ten-year 5.1 million mortgage note bearing interest at a fixed rate of 3.50 per annum with monthly principal and interest payments due based on a twenty-five-year amortization schedule. 